Not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.
PSC Trial Watch
UCRecruiting

Personalised Prediction of Disease Course in Ulcerative Colitis Using Multimodal Machine Learning - Part of the Presager Project

Observational · No treatment assigned · 1 site · Copenhagen University Hospital, Hvidovre

Official record & contacts on ClinicalTrials.gov ↗

In plain English

What this trial is testing

Condition(s) listed: Ulcerative Colitis. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.

Who can join

Some of the main requirements, copied from the record:

Plus 2 more requirement(s). Only the trial team can confirm whether you qualify.

What's involved

Main thing being measured

In the researchers’ words

In patients achieving clinical remission following a flare, artificial intelligence can reliably predict a new flare within the next 12 months utilizing clinical and objective information at day 0 and week 8. Secondary endpoints: * An artificial intelligence model's precision in predicting a new flare within 2 and 3 years * An artificial intelligence model's precision to rule out patients who will not experience a…

This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.

Questions to ask your doctor and the trial team

Official details

StatusRecruiting
PhaseObservational
Study typeObservational
ConditionsUlcerative Colitis
Lead sponsorCopenhagen University Hospital, Hvidovre
Enrollment400 (estimated)
Start date2022-06-20
Primary completion (est.)2025-12
First posted2022-07-29
Last updated2025-02-27
Official titlePersonalised Prediction of Disease Course in Ulcerative Colitis Using Multimodal Machine Learning - Part of the Presager Project
ClinicalTrials.gov IDNCT05479617

Interventions

Full eligibility criteria (from the record)
Inclusion criteria:

* Signed informed consent
* Diagnosis of UC for at least 1 year
* Relapse due to UC.
* First endoscopic and histological evaluation of the flare Exclusion criteria
* Well-founded doubt that the flare is due to other than the patients UC

Locations (1)

SiteCityCountrySite status
Gastrounit, medical section, Copenhagen University Hospital HvidovreHvidovre, DenmarkDenmarkRecruiting

For contacts at each site, use the official record.

Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.